APA (7th ed.) Citation

HC, S., HW, L., & KW, T. (2025). Efficacy and Safety of Cyclin-Dependent Kinase 4/6 Inhibitors in Patients with Breast Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials and Real-World Studies. Targeted oncology, 20(1), 71. https://doi.org/10.1007/s11523-024-01118-0

Chicago Style (17th ed.) Citation

HC, Su, Lin HW, and Tam KW. "Efficacy and Safety of Cyclin-Dependent Kinase 4/6 Inhibitors in Patients with Breast Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials and Real-World Studies." Targeted Oncology 20, no. 1 (2025): 71. https://doi.org/10.1007/s11523-024-01118-0.

MLA (9th ed.) Citation

HC, Su, et al. "Efficacy and Safety of Cyclin-Dependent Kinase 4/6 Inhibitors in Patients with Breast Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials and Real-World Studies." Targeted Oncology, vol. 20, no. 1, 2025, p. 71, https://doi.org/10.1007/s11523-024-01118-0.